《新股消息》傳人臉識別AI獨角獸曠視科技研押後港IPO
據《彭博通訊社》引述消息稱,提供包括人臉識別等人工智能(AI)解決方案的內地獨角獸企業曠視科技,正研究押後在港上市。曠視科技被美國列入「實體清單」,其能否獲得現時40億美元估值存在不確定性。
曠視科技正與顧問討論是否按原計劃本月推進在港掛牌,或押後上市。有消息稱,是次上市安排,曠視科技要獲得35億美元估值亦存在難度。公司已分別獲阿里集團及天使投資者創新工場投資,消息稱,在最近一輪融資,其估值達40億美元。
消息稱,曠視科技未作最終決定,其仍計劃本月舉行上市聆訊。公司對估值的討論仍未落實。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.